Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L, Hirschmann A, Hofman P, Bontoux C, Concha A, Mrabet-Dahbi S, Vannuffel P, Watkin E, Putzová M, Scarpino S, Cayre A, Martin P, Stoehr R, Hartmann A. Melchior L, et al. Among authors: hofman p. Virchows Arch. 2024 Nov;485(5):959. doi: 10.1007/s00428-024-03800-0. Virchows Arch. 2024. PMID: 38639799 Free PMC article. No abstract available.
Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L, Hirschmann A, Hofman P, Bontoux C, Concha A, Mrabet-Dahbi S, Vannuffel P, Watkin E, Putzová M, Scarpino S, Cayre A, Martin P, Stoehr R, Hartmann A. Melchior L, et al. Among authors: hofman p. Virchows Arch. 2024 Apr;484(4):677-686. doi: 10.1007/s00428-024-03778-9. Epub 2024 Mar 16. Virchows Arch. 2024. PMID: 38492039 Free PMC article.
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists.
Kerr KM, Bubendorf L, Lopez-Rios F, Khalil F, Roy-Chowdhuri S, Joubert P, Hartmann A, Guerini-Rocco E, Yatabe Y, Hofman P, Cooper WA, Dacic S. Kerr KM, et al. Among authors: hofman p. Histopathology. 2024 Feb;84(3):429-439. doi: 10.1111/his.15078. Epub 2023 Nov 13. Histopathology. 2024. PMID: 37957137 Review.
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology.
Ilié M, Lake V, de Alava E, Bonin S, Chlebowski S, Delort A, Dequeker E, Al-Dieri R, Diepstra A, Carpén O, Eloy C, Fassina A, Fend F, Fernandez PL, Gorkiewicz G, Heeke S, Henrique R, Hoefler G, Huertas P, Hummel M, Kashofer K, van der Laak J, de Pablos RM, Schmitt F, Schuuring E, Stanta G, Timens W, Westphalen B, Hofman P. Ilié M, et al. Among authors: hofman p. Virchows Arch. 2024 Nov;485(5):761-775. doi: 10.1007/s00428-024-03933-2. Epub 2024 Oct 2. Virchows Arch. 2024. PMID: 39354109 Review.
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G, Melocchi V, Dama E, Hofman P, De Luca M, Albini A, Gemelli M, Ricotta R, Papotti M, La Rosa S, Uccella S, Harari S, Sonzogni A, Asiedu MK, Wigle DA, Bianchi F. Pelosi G, et al. Among authors: hofman p. Exp Mol Pathol. 2024 Feb;135:104882. doi: 10.1016/j.yexmp.2024.104882. Epub 2024 Jan 20. Exp Mol Pathol. 2024. PMID: 38237798 Free article.
Real-world incidence and risk factors of pneumonitis in chemoradiation plus immune checkpoint inhibitors compared with chemoradiation alone in lung cancer: a retrospective cohort study.
Pu D, Liu Q, Zhang S, Wang L, Xu F, Hofman P, Giusti R, Zhou Q, Li X, Li L. Pu D, et al. Among authors: hofman p. Transl Lung Cancer Res. 2024 Jan 31;13(1):139-151. doi: 10.21037/tlcr-23-756. Epub 2024 Jan 12. Transl Lung Cancer Res. 2024. PMID: 38405001 Free PMC article.
1,154 results